Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia

Waseem, Husnain; Felipe, Carlos Henriquez; Hashmi, Arsalan Talib; Ansar, Maham; Batool, Asiya; Saverimuthu, Angela; Kamholz, Stephan L.

doi:10.1097/00045391-900000000-98534

American Journal of Therapeutics

2018

DOI: 10.1097/00045391-900000000-98534

|View full text |Cite

Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia

Husnain Waseem

Carlos Henriquez Felipe

Arsalan Talib Hashmi

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[10][11][12][13][14][15] To the best of our knowledge, only two cases of ''Ara-C-related RES'' have been reported in the past. 16,17 To conclude, RES is a rare Ara-C-related skin toxicity and physicians should be aware of its presentation, differential diagnosis, and management. It is essential to rule out infective process especially viral illnesses while evaluating possible cases of RES.…”

mentioning

confidence: 99%

Ara-C Related Red Ear Syndrome

2019

View full text Add to dashboard Cite

Hersh and Hersh in their recent article ''Red ear syndrome: Perspectives for the otolaryngologist'' explicitly discussed about the Red ear syndrome (RES) and related otorhinological conditions. 1 Ara-C, an anticancer drug, is known to cause multiple nonhematological toxicities such as cerebellar dysfunction, conjunctivitis, skin toxicity, and liver dysfunction. 2 Skin toxicity in the form of palmoplantar-erythrodysesthesia (PPE) is well reported. Here in, we describe a dermatological manifestation similar to PPE but limited only to ears. 3 Through the following case, we would like to discuss ''RES'' from hematologist's standpoint as an important dermatological side effect.A 36-year-old female was started on induction chemotherapy (Ara-C 200 mg/m 2 /day Â 7 days and daunorubicin 60 mg/m 2 / day Â 3 days) for newly diagnosed acute myeloid leukemia (AML). On the fourth day of therapy, she started developing blanchable, discrete, nonpruritic, nonpalpable, erythematous discrete over the skin of both ears (Figure 1, panel A). There were no similar lesions in other parts of the body. She denied headache, excluding the possibility of trigeminal autonomic cephalalgias. These skin lesions gradually coalesced by the fifth day to appear as diffusely erythematous ''red ear.'' Her kidney and liver function tests were normal and blood counts suggested chemotherapy-induced myelosuppression (hemoglobin-9.1 g/dL, leukocyte count-0.8 Â 10 9 /L, and platelet count-90 Â 10 9 /L). Viral serologies for cytomegalovirus, epstein-barr virus, herpes simplex virus etc. were negative ruling out the

show abstract

mentioning

confidence: 99%

Ara-C Related Red Ear Syndrome

2019

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia

Cited by 1 publication

References 0 publications

Ara-C Related Red Ear Syndrome

Ara-C Related Red Ear Syndrome

Contact Info

Product

Resources

About